After-Hours Market Recap
U.S. stocks saw volatile after-hours action on Tuesday, with major moves across the tech, healthcare, and consumer sectors following a flurry of earnings reports and updated forecasts.
Leading the headlines were Palantir Technologies, Hims & Hers Health, and Clorox, each reacting sharply to quarterly results that underscored how investor sentiment continues to hinge on AI adoption, consumer spending, and cost management.
Palantir Rallies on AI Contract Momentum
Shares of Palantir Technologies (PLTR) jumped 8% in extended trading after the data analytics company posted stronger-than-expected earnings and guided for higher full-year revenue.
The company reported $713 million in Q3 revenue, up 20% year-over-year, driven by a surge in demand for its AI-driven government and enterprise platforms. Adjusted earnings per share came in at $0.08, surpassing Wall Street expectations.
CEO Alex Karp said the company is seeing “unprecedented interest in AI defense and decision systems,” with several new U.S. and international contracts in the pipeline.
“AI is no longer theoretical, it’s operational,” Karp said. “Our customers are deploying it to solve real-world problems at scale.”
Palantir’s stock, which has already climbed more than 40% this year, continues to benefit from its positioning at the intersection of AI infrastructure and national security technology.
Hims & Hers Health Pops After Strong Demand and Profit Outlook
Telehealth platform Hims & Hers Health (HIMS) saw its shares surge 11% after hours as the company delivered quarterly results that topped analyst estimates and boosted its full-year outlook.
Revenue rose 45% year-over-year to $287 million, driven by rapid growth in personalized subscription products for hair loss, skincare, and mental health treatments.
The company also posted a surprise profit, its first ever on a GAAP basis, as recurring customer growth hit record highs.
“We’re building one of the most trusted consumer health brands in America,” said CEO Andrew Dudum. “AI-driven personalization is helping us scale faster and connect more deeply with patients.”
Investors cheered the results as a signal that direct-to-consumer healthcare models are becoming more sustainable, particularly as digital prescriptions and online consultations gain mainstream acceptance.
Clorox Falls on Weaker Margins Despite Stable Sales
In contrast, Clorox (CLX) fell 6% in after-hours trading after reporting mixed quarterly results and warning of continued margin pressure from elevated logistics and input costs.
While revenue came in at $1.87 billion, roughly in line with expectations, profit margins narrowed due to higher manufacturing expenses.
CEO Linda Rendle said the company remains focused on rebuilding resilience following a challenging 2024 marked by supply chain disruptions and cybersecurity incidents.
“We’ve made progress restoring operations, but inflationary headwinds persist,” Rendle noted.
Analysts described the results as steady but uninspiring, with many pointing to ongoing cost concerns across the consumer goods sector.
Other Notable Movers
-
Advanced Micro Devices (AMD): Edged up 2% after new reports suggested the chipmaker secured additional AI chip supply deals with major cloud providers.
-
Uber Technologies (UBER): Gained 3% following confirmation of an expanded delivery partnership with Costco in key U.S. markets.
-
SoFi Technologies (SOFI): Declined 4% as investors digested mixed signals from the company’s fintech lending outlook.
Market Context
The broader after-hours session reflected investor caution as markets digested a busy day of corporate earnings alongside renewed debate over Federal Reserve policy.
While futures for the S&P 500 and Nasdaq 100 showed modest gains, traders remain watchful for economic data later in the week, particularly inflation reports that could influence the Fed’s next move.
“Earnings remain the market’s main driver right now,” said Savita Subramanian, head of U.S. equity strategy at Bank of America. “Investors are rewarding companies showing AI execution and punishing those facing margin pressure.”
The Bottom Line
From Palantir’s AI-fueled surge to Clorox’s cost struggles, after-hours trading showcased a market still sharply divided between growth and defensiveness.
As investors await fresh economic data and Fed commentary, earnings execution, not just outlook, is defining the winners and losers of this volatile earnings season.
